The activity of the [2831; 1103] promoter of the human cyclooxygenase-2 gene in cultured rabbit chondrocytes is stimulated 2.9^0 sequence binds with a low affinity both the p50/p50 homodimeric and p50/p65 heterodimeric forms of NF-kB but has no role in the regulation of the human COX-2 promoter in chondrocytes.
Arthritic joints produce large quantities of prostaglandins, mainly prostaglandin E 2 (PGE 2 ). PGE 2 may be involved in the erosion of cartilage and juxtaarticular bone, and the induction of angiogenesis [1±3] . PG production is initiated by the two isoforms of cyclooxygenase, COX-1 and COX-2 (reviewed in [4, 5] ). These bifunctional enzymes convert arachidonic acid released from membranes by phospholipases A 2 [4] into PGG 2 (cyclooxygenase activity) and then PGG 2 into PGH 2 (hydroperoxidase activity). PGH 2 is converted into PGE 2 by a specific isomerase. COX-1 is a constitutive enzyme, while COX-2 gene expression is readily induced by inflammation [5] .
Although IL-1a stabilizes COX-2 mRNA in human umbilical vein endothelial cells (HUVEC) [6] , most work on the regulation of COX-2 gene expression emphasizes the role of several transcription factors, such as NF-kB and C/EBP family members. NF-kB acts on the human promoter at two putative sites, one at 2448/2439 and the other at 2223/2214 (Fig. 1A) . The proximal site is involved in the stimulation of COX-2 gene transcription by hypoxia in HUVEC [7] . The mouse sequence homologous to the human distal site takes part in induction of the activity of the rodent promoter by TNFa in the osteogenic cell line MC3T3-E1 [8] , and the binding of NF-kB to both the proximal and distal sites is correlated with the stimulation of COX-2 gene expression by IL-1b in human rheumatoid synoviocytes [9] . However, the mouse distal NF-kB site does not contribute to the induction of the promoter activity by LPS in RAW 264.7 macrophages [10] and mutation of the rat homologous sequence does not suppress the stimulation of the activity of the rat COX-2 promoter by TNFa in rat vascular smooth muscle cells [11] , or the basal promoter activity in the pancreatic islet cell line HIT-T15 [12] .
C/EBP factors are also involved in regulating the activity of the COX-2 promoter. There is a C/EBP binding site on the human promoter at positions 2132/2124 downstream of an adjacent AP-2 site, which plays a role in the induction of the promoter activity by LPS in vascular endothelial cells [13] . The rat homolog of this C/EBP binding site is involved in cAMPdependent regulation of COX-2 transcription by FSH and LH in rat granulosa cells [14] , and in basal promoter activity in the pancreatic islet cell line HIT-T15 [12] and in the mouse skin [15] . The C/EBP family contains three main activating members, C/EBPa, C/EBPb and C/EBPd, which all recognize the same DNA sequence. C/EBPa is involved in hepatic and adipogenic differentiation, while C/EBPb and C/EBPd are responsible for the induction of several acute phase genes by IL-6 in the liver. Treating mice with LPS increases the transcription rate of the C/EBPb and C/EBPd genes in their kidneys and livers [16] . Phosphorylation of C/EBPb by MAP kinases also increases the transactivating ability of this factor [17] . C/EBPa, C/EBPb and C/EBPd proteins have a common structure, with an N-terminal domain bearing the transactivation domain, a basic DNA-binding domain and a C-terminal domain containing a leucine zipper, which allows the homo-or heterodimerization of these factors [18] .
Finally, the activities of the rodent and human COX-2 promoters are regulated by a proximal element that is located 20 bp upstream of the TATA box, but there are conflicting data on the role and the nature of the proteins bound to this promoter [10±14,19±23] . This element contains a perfect E-box 5 H -CACGTG-3 H in the mouse and rat promoters, but the homologous sequence on the human promoter differs by one base pair [19] (Fig. 1 ). An ATF/CRE 5 H -CGTCAC-3 H overlaps the E-box in the murine and human promoters [20, 21] . Different factors therefore bind to this proximal element, depending on the species and on the cell. ATF and CREB family members bind to the murine sequence in NIH3T3 cells, but the response to mitogenic stimuli in these cells is mediated by c-jun, which heterodimerizes with the ATF family members [22, 23] . The rat COX-2 promoter is also not recognized by ATF/CRE activities in ovarian granulosa cells, but the E-box binds USF factors and is required for basal transcription and its stimulation by hormones [19] . The ATF/CRE sequence is also required for basal expression of the human COX-2 gene in the macrophage cell line U937 [21] and actually binds C/EBPd instead of ATF/CREB family members in vascular endothelial cells transfected by C/EBP expression vectors [13] . Both this sequence and the distal 2132/2124 C/EBP binding site are required for the human COX-2 promoter to be induced by LPS in these cells [13] . In contrast, the E-box is not required for induction of the promoter activity by LPS in RAW 264.7 macrophages while mutation of the CRE sequence drastically reduces both the basal and stimulated transcription activities [10] .
IL-1b causes expression of both the type IIA secreted phospholipase A 2 (sPLA 2 -IIA) [25] and the COX-2 genes [24] in chondrocytes. Arachidonic acid may be provided to COX-2 by sPLA 2 -IIA, and we have demonstrated that the binding of sPLA 2 -IIA to chondrocyte membranes correlates with increased PGE 2 production [24] . COX-2 and sPLA 2 -IIA are therefore functionally linked. We have also shown that C/EBPd plays a critical role in the activation of the sPLA 2 -IIA promoter by IL-1b in primary cultures of rabbit chondrocytes [25] . The present study was undertaken to determine whether both sPLA 2 -IIA and the COX-2 gene can be induced by the same transcription factors in response to IL-1b and whether these factors may be putative therapeutic targets at which to block inflammation. We examined the roles of the C/EBP family members and their collaboration with c-rel family members in the regulation of COX-2 gene transcription in chondrocytes. We also characterized other transcription factors, specifically the USF proteins, that recognize regulatory elements in the human COX-2 promoter and determined the contributions of each of these cis-elements to IL-1b-stimulated transcription.
M A T E R I A L S A N D M E T H O D S

Materials
Restriction enzymes, T4 kinase, ligase and Taq polymerase were purchased from Biolabs (USA). Oligonucleotides were provided by Oligoexpress (France). Materials for cell culture and protein molecular weight markers were from Sigma (USA) (Dulbecco's modified Eagle's medium, HAM's F12 medium, fetal bovine serum, Hepes, trypsin, glutamine, penicillin± streptomycin), Gibco BRL (Gey medium) and Costar (USA) (flasks and Petri dishes). The b-galactosidase expression vector CMVb-gal was obtained from Clontech (USA), and poly(dI´dC) and deoxynucleotides from Pharmacia (Sweden). Radioactive products were supplied by Amersham (UK). Collagenase, hyaluronidase and trypsin for preparing monolayers of rabbit chondrocytes were supplied by Boehringer Mannheim (France). The antibodies against the NK-kB subunits p50 and p65 and the C/EBP family members C/EBPa, C/EBPb and C/EBPd were provided by Santacruz Biotechnology (USA). The antibodies to USF1 and USF2 were gifts from M. Raymondjean (ICGM Cochin, Paris, France).
Chondrocyte cultures and transfections
Female 3-week-old Fauve de Bourgogne rabbits were killed and the shoulders, knees and femoral heads were dissected out under sterile conditions [26] . The articular cartilage was removed, cut into small pieces, and digested at 37 8C with 0.05% hyaluronidase in Gey medium for 15 min, then with 0.25% trypsin for 30 min, and lastly with 0.2% collagenase for 90 min. The resulting chondrocytes were washed in HAM's F12 medium without fetal bovine serum for 60 min, suspended in HAM's F12 medium supplemented with 10% fetal bovine serum and seeded into 60 mm dishes (1.5 Â 10 5 cells per dish). The cells were maintained at 37 8C in 5% CO 2 and the culture medium was changed every 2±3 days. The cells reached preconfluency within 6±7 days.
Chondrocytes were transfected using the calcium phosphate DNA coprecipitation method [27] . Cells were placed in DMEM and incubated with the transfection mixture containing 12 mg pUC-SH-CAT constructs and 2.5 mg of plasmids bearing the b-galactosidase gene, for 4 h. They were then shocked with HBS buffer (21 mm Hepes, pH 7.1, 16 mm dextrose, 0.8 mm NA 2 HPO 4 , 5 mm KCl, and 137 mm NaCl) containing 15% glycerol for 90 s. The treated cells were incubated for 20 h in HAM's F12 without fetal bovine serum and grown for an additional 24 h in HAM's F12 without fetal bovine serum, with or without IL-1b (10 ng´mL
21
). The harvested cells were lysed by incubation with 50 mL 100 mm Tris pH 7.8, 0.7% NP40 for 15 min at 4 8C. CAT activities were measured by the two-liquid phases method [28] . b-Galactosidase activities were measured to normalize variations in transfection efficiency. Transfection experiments were performed in duplicate and repeated four times with two different preparations of plasmids. The PHD expression vectors containing the C/EBPb and C/EBPd cDNAs were a gift from G. Ciliberto (IRBM, Rome, Italy). The expression vector of the undegradable mutant of I-kB was generously given by A. Israe Èl (Paris, France).
Plasmid constructions
Preparation of nuclear extracts and cell lysates
Nuclear extracts of chondrocytes were prepared as previously described [29] . Briefly, confluent cells from three P100 dishes were grown in HAM's F12 without fetal bovine serum and then incubated in HAM's F12 with or without IL-1b (10 ng´mL 21 ) for 24 h. They were then washed and scraped off in NaCl/P i . The cells were centrifuged at 1500 g for 5 min and the pellet was suspended in 500 mL buffer A (5 mm Hepes pH 7.9, 1.5 mm MgCl 2 , 10 mm KCl, 0.5% NP40, 0.5 mm dithiothreitol, 0.1 mm phenylmethanesulfonylfluoride, 5 mg´mL 21 leupeptin, 50 mm NaF). The cells were incubated at 4 8C for 15 min, centrifuged at 6000 g for 10 min, and the pellet suspended in 100 mL buffer C (20 mm Hepes pH 7.9, 25% glycerol, 0.5 m NaCl, 1.5 mm MgCl 2 , 0.5 mm EDTA, 0.5 mm dithiothreitol, 0.5 mm phenylmethanesulfonylfluoride, 5 mg´mL 21 leupeptin, 50 mm NaF). The nuclei were lysed by pipetting up and down four times and incubating for 30 min at 4 8C. The lysates were centrifuged at 100 000 g for 30 min at 4 8C in a TLC centrifuge (Beckman, USA). The supernatants were collected and the protein concentrations were measured according to Kalb & Berlohr [30] . The nuclear protein batches were stored at 280 8C. Lysates of COS-1 cells were prepared 40 h after transfection of the cells with the C/EBP expression vectors according to Olivier et al. [31] .
Bandshift assays
H ) oligonucleotides corresponding to the regulatory elements of the human COX-2 promoter and the KBEwt oligonucleotide (5 H -ACAGAGGGGACTTTCCGAGAG-3 H ) corresponding to the enhancer of the light chain k gene [32] were used as probes. These double-stranded oligonucleotides (100 ng) were labeled using T4 kinase and 50 mCi [g-32 P] ATP. Free nucleotides were separated from the labeled probe on a Sephadex G50 column. The specific activity of the probe was estimated by spotting 1 mL of the labeling mixture (before the G50 column) onto a TLC plate, separating the labelled probe and free nucleotide by chromatography and counting them. The specific activities were 1±2 Â 10 8 cpm´mg
21
. Chondrocyte nuclear extracts (6±9 mg) were incubated at 4 8C for 15 min in a 20-mL reaction solution containing 25 mm Hepes pH 7.6, 8% Ficoll, 40 mm KCl, 5 mm MgCl 2 , 1 mm dithiothreitol, and 3 mg of double-stranded poly(dI´dC). When double-stranded competitor oligonucleotides were used, they were added in a volume of 1 mL and the reaction mixture was incubated with the nuclear extracts at 4 8C for 15 min before adding the probe. The competitors used in bandshift assays were the D-Alb oligonucleotide 5
H -TGGTAT-GATTTTGTAATGGGGTAGGA-3 H , which corresponds to the element D of the murine albumin promoter and binds C/EBP proteins [33] , and the USF oligonucleotide 5
H -TGGTCACGT-GGCCTACACCTATAA-3 H , which corresponds to the enhancer of the murine immunoglobin heavy chain gene and binds USF proteins [34] . The sequences of the other oligonucleotides used as competitors are indicated in the corresponding figures. Double-stranded oligonucleotide probes (100 000 cpm) were then added and the incubation was continued for 30 min at 4 8C. Free DNA and DNA±protein complexes were resolved by electrophoresis in 5% or 7% polyacrylamide gels in 6.7 mm Tris/HCl, 3.3 mm sodium acetate, 1 mm EDTA, pH 7.9. The gels were dried and exposed to X-OMATw film (Kodak, USA). In supershift experiments, chondrocyte nuclear extracts were preincubated for 15 min at 4 8C with 1 mL of specific antibodies.
R E S U L T S
Requirement of the [2261; 281] fragment of the human COX-2 promoter for stimulation of its activity by IL-1b in chondrocytes
The human COX-2 promoter contains two putative binding sites for NF-kB and the C/EBP factors (Fig. 1A) . The proximal putative C/EBP binding sequence is also a putative ATF/CRE site overlapping an E-box-like sequence. We named the elements containing the proximal CRE and the distal C/EBP binding sites COX2-A and COX2-B, respectively, and the elements enclosing the putative NF-kB sites COX2-C and COX2-D (Fig. 1A) . Primary cultures of rabbit chondrocytes were transiently transfected by CAT constructs containing 5
H -deleted fragments of the COX-2 promoter to determine the regions responsible for stimulation by IL-1b. Incubating the cells with IL-1b for 24 h increased the activity of the [2831; 1103] fragment of the COX-2 promoter 2.9^0.3-fold (Fig. 1B) . The stimulation of the promoter activity by IL-1b was not modified by deletions down to the 2261 position; the last deletion removed the putative distal 2448/ 2439 NF-kB binding site (Fig. 1A,B The oligonucleotide corresponding to the [2140; 2116] COX2-B element formed two complexes with the chondrocytes nuclear extracts, B1 and B2, whose intensities were increased when the cells were first treated with IL-1b ( Fig. 2A , compare lanes 1 and 2). Both these complexes were competed out by 100-fold excesses of the unlabeled COX2-B, COX2-A and D-Alb oligonucleotides. The D-Alb oligonucleotide corresponds to the D enhancer of the murine albumin promoter, which binds C/EBP factors [33] (Fig. 2A, lanes 3±5 ). This result confirms that the COX2-B and COX-2A elements bind C/EBP family members. An antibody against C/EBPa did not alter any of the B1 and B2 complexes (Fig. 2A, lane 6) . Because all the C/EBP family members have the same binding site, rabbit articular chondrocytes probably do not produce C/EBPa. Antibodies to C/EBPb and C/EBPd totally supershifted the B1 complex ( Fig. 2A, lanes 7, 8) . By contrast the B2 complex was only partially displaced by both these antibodies ( Fig. 2A, lanes 7 and 8) . Considering that C/EBPb and C/EBPd bind to DNA by forming heterodimers as well as homodimers, these data indicate that the B1 complex is formed by C/EBPb± C/EBPd heterodimers, while the B2 complex is heterogeneous and corresponds to comigrating C/EBPb±C/EBPb and C/EBPd±C/EBPd homodimers.
Mutation of the [2132; 2124] C/EBP binding sequence in a CAT construct containing the [2261; 1103] fragment of the COX-2 promoter suppressed the stimulation of the transcription activity by IL-1b in primary culture chondrocytes (Fig. 2B) . (Fig. 2B) . These results indicate that C/EBPb and C/EBPd must bind to the COX2-B element for the transcription of the human COX-2 gene to be stimulated by Il-1b in primary cultures of chondrocytes; they also suggest that C/EBPb and C/EBPd have alternative effects that might be mediated through their binding to the COX2-A element. The COX2-A element formed three complexes with the chondrocyte nuclear extracts, A1, A2 and A3 (Fig. 3B, lane 1) . The A1 and A2 complexes migrated very close together and were barely resolved. There was also a smeared band migrating just below the A1 complex and superimposed on the A2 complex. The intensities of the A1, A2 and A3 complexes were increased when the cells were treated with IL-1b prior to extraction of the nuclear proteins (Fig. 3B, compare lanes 1 and 2) . The A2 and A3 complexes were competed out by a 100-fold excess of the unlabeled C/EBP binding oligonucleotide D-Alb (Fig. 3C, lane  2) . The A2 and A3 complexes were supershifted by antibodies against C/EBPb and C/EBPd, but not by antibodies to C/EBPa (Fig. 3C, lanes 3±6) , similarly to the B1 and B2 complexes formed with the COX2-B element. This indicates that these complexes corresponded to homodimers or heterodimers of C/EBPb and C/EBPd, like the B1 and B2 complexes. The formation of the A1 complex was prevented by adding a 100-fold excess of the USF binding oligonucleotide and the antibody to USF1/2 (Fig. 3C, lanes 6 and 7) . The [262; 250] 5 H -CATTTCGTCACAT-3 H sequence must be responsible for the formation of the A1 and A3 complexes, because their formation was not impeded by adding a 100-fold excess of the unlabeled oligonucleotide Am1, in which this sequence was mutated (Fig. 3A and Fig. 3C, lane 8) . Two oligonucleotides, Am2 and Am3, which contain mutations of the 260/258 and 252/251 nucleotides, respectively, were also used as competitors to localize the C/EBP and USF binding sites within the [262; 250] sequence (Fig. 3A,D) . The A2 and A3 complexes were competed out by the Am3 oligonucleotide, but not by Am2 (Fig. 3D, lanes 1 and 2) . By contrast, the complex A1 was competed out by the Am2 oligonucleotide, but not by Am3 (Fig. 3D, lanes 1 and 2) . Finally, the smeared band migrating just below the A1 complex was not suppressed by 100-fold excesses of C/EBP-binding or Am3 competitors (Fig. 3C and Fig. 3D, lanes 2) . These results indicate that the 260/258 nucleotides are critical for the binding of C/EBP family members, which generate the A2 and A3 complexes. These nucleotides are located just upstream of the putative ATF/CRE sequence 5 H -CGTCAC-3 H (Fig. 3A) . They also show that the [256; 251] 5 H -GTCACA-3 H E-box-like sequence, which is altered in the Am3 oligonucleotide, is involved in the binding of USF.
Mutation of the whole [262; 250] sequence in the COX2-A element suppressed the stimulation of the [2261; 1103] promoter activity by IL-1b. It also suppressed the stimulation of the promoter activity by exogenous C/EBPb and greatly reduced that by C/EBPd (Fig. 4) . Surprisingly, individual mutations of the USF or C/EBP binding sites similar to those performed in the Am2 and Am3 oligonucleotides did not alter the induction by IL-1b. Transactivations by exogenous C/EBPb and C/EBPd were slightly decreased by the Am2 mutation but unaffected by the Am3 mutation (Fig. 4) . Finally, the Am1, Am2 and Am3 mutations did not significantly modify the basal activity of the [2261; 1103] promoter (Fig. 4) . Although C/EBPb and C/EBPd bind to the COX2-A as well as to the COX2-B elements, these results indicate that their binding to these two elements have different consequences. The binding of C/EBPb and C/EBPd to the COX2-B element is critical for stimulation of the promoter activity by IL-1b, while C/EBP factors can be replaced by USF on the COX2-A elements to induce COX-2 gene transcription in chondrocytes. This aspect of the regulation of the COX-2 gene transcription is further discussed below.
NF-kB binds to the 2448/2439 and 2223/2214 sequences of the human COX-2 promoter but the 2223/2224 sequence is involved in the regulation of transcription by IL-1b in chondrocytes
We identified the contribution of NF-kB to the stimulation of the activity of the human COX-2 promoter in chondrocytes by determining whether this factor actually bound to the putative proximal and distal sites. NF-kB is formed by the association of two subunits, p50 and p65. The p65 subunit supports a strong transactivation ability but has a poor affinity for DNA, while p50 binds strongly to DNA but is poorly active [35] . NF-kB is translocated to the chondrocyte nuclei during the first hour of The CAT construct were cotransfected with the PHD expression vectors containing C/EBPb (dotted bars) or C/EBPd (dashed bars) cDNAs. CAT activities were normalized by using b-galactosidase activities. Results are expressed as the means^SEM of three independent experiments performed in duplicate.
stimulation by IL-1b, and its nuclear binding remains unchanged for up to 24 h, as shown by bandshift experiments using the enhancer of the light chain k gene as a probe (KBEwt probe) (data not shown). The oligonucleotide corresponding to the [2233; 2214] COX2-C element formed two complexes with nuclear extracts from IL-1b-treated chondrocytes, the major one having the higher electrophoretic mobility (Fig. 5A,  lane 1) . The lower mobility complex was only partially competed out by a 100-fold excess of unlabeled KBEwt oligonucleotide, while the high mobility one was totally displaced (Fig. 5A, lane 2) . The higher mobility complex was supershifted by an antibody to p50 but not by an antibody to p65, indicating that it is formed by the p50/p50 homodimer (Fig. 5A, lanes 3 and 4) . By contrast, the lower mobility complex was not afffected by incubating the chondrocyte nuclear extracts with the antibodies against p50 and p65 (Fig. 5A, lanes  3 and 4) . These results show that the lower mobility complex is formed by a protein differing from the canonical p50 and p65 c-Rel family members. The oligonucleotide corresponding to the [2455; 2433] COX2-D element also formed two complexes with the chondrocyte nuclear extracts (Fig. 5B, lane 1) . Both these complexes were competed out by a 100-fold excess of unlabeled KBEwt oligonucleotide (Fig. 5B, lane 2) . The upper complex must be generated by the p50/p65 heterodimer, because it was supershifted by the antibodies to both p50 and p65, while the lower one was supershifted only by the antibody to p50 (Fig. 5B, compare lanes 3 and 4) , indicating that this complex was formed by the p50/p50 homodimer. Various amounts of chondrocyte nuclear extract were incubated with the COX2-C, COX2-D and KBEwt probes to compare their affinity for NF-kB. The canonical KBEwt probe bound mainly to the p50/p65 heterodimer (Fig. 6, lanes 1±4) . The complex formed between the KBEwt probe and the p50/ p65 heterodimer was much more intense than either of the complexes formed between the COX2-D probe and 6±12 mg of nuclear extracts from IL-1b-treated chondrocytes (Fig. 6 , compare lanes 2±4 to lanes 6±8). This result shows that the COX2-D element has a low affinity for NF-kB, especially for the transcriptionally active p50/p65 heterodimer. The COX2-C probe bound only the p50/p50 homodimer in chondrocytes nuclear extract concentrations of 6±12 mg (Fig. 6, lanes 9±12) .
Mutation of the [2448; 2449] 5 H -GGGGATTCCC-3 H NF-kB site of the COX2-D element in the [2831; 1103] fragment of the human COX-2 promoter did not modify the induction of (Fig. 7) . This indicates that, although it does not bind the transcriptionally p50/p65 active form of NF-kB, the COX2-C element plays a critical role in the regulation of the human COX-2 promoter by IL-1b in primary cultures of chondrocytes, in addition to the the C/EBP binding COX2-B element.
D I S C U S S I O N
We have shown that C/EBPb and C/EBPd factors bind to the COX2-B element in chondrocyte primary cultures and that this binding is required for stimulation of the COX-2 promoter by IL-1b in chondrocytes, as both the 5 H deletion and the mutation of this sequence suppressed the effect of IL-1b. We have previously shown that IL-1b stimulates expression of the C/EBPd gene without affecting that of the C/EBPb gene [25] . Enhancements of the intensities of the complexes formed with the COX2-B probes in bandshift experiments are likely to be due to the increased C/EBPd protein bound to DNA, either as a homodimer or a heterodimer with C/EBPb. Such critical roles for C/EBPb and C/EBPd have been recently described by Wadleigh et al. [10] in the induction of the mouse COX-2 promoter activity by LPS in RAW 264.7 macrophages. These authors found two C/EBP binding sequences, one corresponding to the human distal site, the other located between the 2138 and 2130 positions [10] . The alteration of the first one reduced more drastically the induction of the promoter activity than the second one and mutations of both these sequences was required to abolish the endotoxin effect. These authors also demonstrated that a CRE sequence in a proximal element corresponding to the human COX2-A element is critical for the basal and stimulated activity of the mouse promoter while the adjacent E-box does not contribute to the transcription activity in RAW 264.7 macrophages [10] .
We found no evidence of the presence of any C/EBP binding site in the human promoter between the COX2-B and COX2-A elements and deletion of the [2170; 281] fragment did not alter the activity of the human promoter in chondrocytes. By contrast, we demonstrated the binding of native C/EBPb and C/EBPd proteins to the COX2-A element in chondrocytes. Inoue et al. [13] also reported the binding of C/EBPd to this element, but they used nuclei of vascular endothelial cells transfected by a C/EBPd expression vector instead of nuclear extracts of native cells in their bandshift experiment. The binding of endogenous vascular endothelial nuclear proteins to the proximal regulatory element of the COX-2 promoter could have been prevented by the overproduced C/EBPd in these experiments. In addition, bandshift experiments also demonstrated USF binding downstream of the C/EBP site in chondrocytes, although Morris and Richards [19] assumed that the COX2-A element of the human promoter would not bind USF family members because of a 1-bp mutation in the E-box compared with the homologous fragment of the rodent promoters. In contrast to the results obtained by Wadleigh et al. [10] , the second C/EBP binding site, i.e. the COX2-A element, is not involved in the stimulation of the human promoter activity by IL-1b in chondrocytes. Surprisingly, exogenously expressed C/EBPb and C/EBPd factors stimulate the activity of mutant fragments of the COX-2 promoter lacking the COX2-B element but containing the COX2-A element. Furthermore, separated mutations of the C/EBP and USF binding sites in the COX2-A element did not alter the stimulation of the transcription activity by IL-1b or exogenously expressed C/EBP factors in chondrocytes while the mutation of both the sites, i.e. the Am1 mutation, drastically reduce these stimulations. We postulate that: (a) C/EBP factors bound to the COX2-B and COX2-A elements interact differently with the general transcriptional machinery; (b) the C/EBP and USF factors bound to the COX2-A element have complementary roles and may work together to transactivate the COX-2 promoter. USF factors regulate the transcription activity of the eukaryotic promoter through their interactions with components of the general transcription factors such as TFII-I [36] and TFII-D [37] . Interactions of C/EBPb with TFII-B, another component of the transcription general machinery, has also been reported either as a direct interaction [38] , or as an indirect interaction mediated by the nucleolar Nopp140 coactivator [39] . Multiple interactions between the numerous components of the general transcription machinery and the transcription factors bound to the proximal regions of the promoter is the usual way of inducing high transcription activity. Alternative interactions of USF and C/EBP factors bound to the COX2-A element with different subunits of the general transcription machinery would explain why mutations of both the USF and C/EBP binding sites are required to decrease the basal promoter activity and to abolish its stimulation by IL-1b. In addition, exogenously expressed C/EBP factors could stimulate the activity of the promoter fragments containing the COX2-A element by increasing the number of interactions with components of the general transcription machinery. The location of the COX2-A element, 24 bp upstream of the TATA box, favors such direct interactions of C/EBP and USF factors with the general transcription machinery. By contrast, such interaction of the C/EBP proteins bound to the far upstream COX2-B element is unlikely and these C/EBP proteins might transactivate the COX-2 promoter in response to IL-1b through their interaction with the CBP/ p300 coactivator [40] . IL-1b might not only increase the concentration of C/EBPd as we previously demonstrated [25] but also qualitatively modify the interactions between C/EBP factors and CBP/p300. This could be mediated through posttranslational modifications of CBP/p300 such as phosphorylations by MAP kinases, which have been previously evidenced [41] . Such hypothesis could explain why the COX2-B element is required for the stimulation of the human COX-2 promoter by IL-1b and the COX2-A element is not sufficient for this stimulation although it could be transactivated by exogenously expressed C/EBP factors. The possible regulatory mechanisms of the various factors that bind to the human COX-2 promoter are summarized in Fig. 8 .
Many eukaryotic promoters, such as those of interleukin-8 [42] , serum amyloid A [43] , interleukin-6 [44] , nitric oxide synthase [45] , intercellular adhesion molecule-1 (ICAM) [46] or manganese superoxide dismutase [47] genes, are regulated through interactions between NF-kB and C/EBP factors. In most cases, these interactions involve p65. In chondrocytes, p50 but not p65 is implicated in the regulation of human COX-2 transcription by IL-1b. The present results show that the distal [2448; 2439] sequence in the COX2-D element binds the p50/ p65 heterodimer and the p50/p50 homodimer with a low affinity and that the proximal [2223; 2214] sequence on the COX2-B element binds only the p50/p50 homodimer. Although it has not been previously reported in the cell types in which the regulation of the COX-2 promoter has been studied, this is consistent with the fact that the 3 H ends of the [2448; 2439] 
